锡诺巴酸盐:来自回顾性多中心研究的现实数据.
Stephan Lauxmann1, David Heuer2, Jan Heckelmann3
1Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tuebingen, Hoppe-Seyler-Str. 3, 72076, Tuebingen, Germany. stephan.lauxmann@uni-tuebingen.de.
Journal of neurology
|July 2, 2024
概括
雪诺巴 (CNB) 是一种有效的抗发作药物,用于治疗严重的耐药性,在现实世界队列中显示出显著的响应率和良好的耐受性. 同时服用抗发作药物的治疗变化也被观察到.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 塞诺巴 (CNB) 是一种已知用于治疗耐药焦点的抗发作药物 (ASM).
- 在各种综合征中对CNB的现实数据有限.
研究的目的:
- 为了评估在广泛的综合征中巴胺 (CNB) 的疗效和安全性.
- 分析 CNB 治疗期间同时服用抗发作药物 (ASM) 的变化.
主要方法:
- 在两个德国第三级推中心对116名接受CNB治疗的患者进行了回顾性观察性研究.
- 分析了长达27个月的随访数据,评估了治疗反应,发作自由,剂量,保留,药物不良反应 (ADR) 和同时发生的ASM变化.
主要成果:
- 50%的患者在6个月后对CNB有反应,在12个月和18个月后持续反应.
- 在6个月后,扣押自由率达到18.4%.
- 总体而言,CNB耐受性良好,ADR导致7.7%的患者停止使用.
结论:
- 雪诺巴 (CNB) 在各种综合征的重症耐药性中表现出高的疗效和耐受性.
- 在焦点之外,CNB代表了一种有价值的治疗选择.
相关概念视频
Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Sedatives and Hypnotics: Overview
2.3K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
2.3K
Sedatives and Hypnotics Drugs: Barbiturates
1.5K
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
1.5K
Sedatives and Hypnotics Drugs: Miscellaneous Agents
990
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
990
Bioavailability Study Design: Single Versus Multiple Dose Studies
388
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
388
Bioavailability Study Design: Healthy Subjects Versus Patients
252
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
252


